Table 2.
Allele frequency and genotype distribution of I/D polymorphism at ACE locus in TCP patients & control subjects
| Patients | Controls | P Value | |||||
| TCP | FCPD | Total | TCP vs. FCPD | TCP vs. controls | FCPD vs. controls | ||
| n | 91 | 80 | 171 | 99 | - | - | - |
| Allele frequency | |||||||
| I | 0.56 | 0.52 | 0.54 | 0.53 | 0.57 | 0.67 | 0.89 |
| D | 0.44 | 0.48 | 0.46 | 0.47 | |||
| Genotype frequency based on the presence or absence of the mutant allele | |||||||
| II | 0.33 (30) | 0.24 (19) | 0.29 (49) | 0.26 (26) | 0.16 | 0.28 | 0.74 |
| ID + DD | 0.67 (61) | 0.76 (61) | 0.71 (122) | 0.74 (73) | |||
n, number of individuals; TCP, tropical calcific pancreatitis; FCPD, fibro-calculous pancreatic diabetes; ACE, angiotensin converting enzyme; I/D, insertion/deletion polymorphism at ACE locus figures in parentheses indicate number of individuals; P values are represented on comparison of TCP with FCPD, TCP with controls and FCPD with controls.